|
Verzögert
OTC Markets
|
Perf. 5 T | Veränd. 1. Jan. | ||
| - USD | -.--% |
|
-.--% | - |
| Manager | Titel | Alter | Seit |
|---|---|---|---|
Brad Nightingale
PSD | Präsident | 56 | - |
Luke Zouvas
LAW | General Counsel | - | - |
| % | % 5 Tage | Perf. 1 Jahr | Perf. 3 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 0 | ||
| +2.83% | +7.48% | +52.08% | +103.85% | 1’077 Mrd. | ||
| +0.86% | -0.87% | +33.00% | +61.40% | 612 Mrd. | ||
| +0.40% | +4.20% | +25.48% | +92.79% | 501 Mrd. | ||
| -1.00% | +3.12% | +74.56% | +40.99% | 364 Mrd. | ||
| +2.37% | +7.66% | +33.65% | +50.58% | 353 Mrd. | ||
| +2.64% | +6.95% | +21.01% | +44.38% | 278 Mrd. | ||
| +3.24% | +6.78% | +0.43% | +15.73% | 251 Mrd. | ||
| +2.65% | +7.31% | +47.06% | +52.41% | 230 Mrd. | ||
| +2.56% | +7.44% | +33.60% | +99.55% | 190 Mrd. | ||
| Durchschnitt | +1.63% | +1.77% | +35.65% | +62.41% | 385.65 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +1.76% | +1.58% | +39.22% | +71.57% |
Beschäftigte
-
Sektor
Pharmazeutika
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















